Top Section/Ad
Top Section/Ad
Most recent
Upper mid-market firms eschew ‘exciting’ stories as cracks emerge in European private credit
Pharmaceuticals and energy transition also ripe sectors for M&A
The US bank has emerged from its restructuring to record impressive market share gains following a reboot of its financial sponsor and leveraged finance businesses
Firm has added to its London team with seventh partner hire this year
More articles/Ad
More articles/Ad
More articles
-
German pharmaceutical firm Stada is seeking €760m in new secured debt to finance recent acquisitions in eastern Europe, with Nomura leading a new senior secured term loan. -
Ohio-based glass manufacturer Owens-Illinois (O-I) sold a euro-denominated green HY issue through BNP Paribas on Thursday, adding to the tiny clutch of leveraged credits to target deals at ESG-oriented investors — and locking in a storming result, with a size increase from €300m to €500m and pricing through the tight end of the initial range.
-
ING has appointed Martjin Bruins as global lead of its structured acquisition finance unit, alongside his existing role as head of the unit in London for origination.
-
A slump in big deals and a quest for fee growth is pushing the big banks into mid-market M&A to an extent that has not been witnessed before, writes David Rothnie.
-
The UK’s SDCL Energy Efficiency Income Trust has completed a €150m debt-backed acquisition of a portfolio of energy generation projects plus debt in Spain, in the company’s largest acquisition since its IPO a year ago.
-
A steady flow of deals is running through the investment grade corporate bond pipeline and out into the market. This is expected to become a deluge before long, as investors’ inboxes are filling up with roadshow invitations.
